This Medicare news weekly recap covers a busy week of updates that could affect how seniors think about prescription drugs, Medicare Advantage plans, prior authorization, remote patient monitoring, and 2027 coverage planning.
The biggest headline this week was the Medicare GLP-1 Bridge Program, which gives eligible Medicare Part D beneficiaries access to certain GLP-1 weight-loss medications for a predictable monthly cost. But that was not the only story worth watching.
Medicare Advantage prior authorization is also under fresh bipartisan scrutiny. Remote patient monitoring is facing more oversight. Large Medicare Advantage carriers are adjusting after a difficult period. And prescription drug coverage rules continue to be one of the most important areas for beneficiaries to review before choosing a plan.
For Medicare beneficiaries, the lesson is simple: Medicare changes quickly, and the details matter.
This Week’s Medicare Headlines at a Glance
Here are the five big Medicare stories from the week of July 20–24, 2026:
- Lawmakers pressed Medicare Advantage insurers over prior authorization and AI-related care denials.
- UnitedHealth Group’s second-quarter results suggested Medicare Advantage enrollment pressure may be stabilizing.
- CMS’s 2027 Physician Fee Schedule proposed rule kept remote monitoring policy in the spotlight.
- Medicare GLP-1 Bridge prior authorization criteria created important documentation questions.
- CMS confirmed the Medicare GLP-1 Bridge will run through December 31, 2027.
Monday: Medicare Advantage Prior Authorization Faces New Scrutiny
One of the biggest Medicare Advantage stories this week involved prior authorization.
U.S. Senators Richard Blumenthal and Josh Hawley pressed major Medicare Advantage insurers for records about prior authorization practices involving post-acute care, including skilled nursing facilities, inpatient rehabilitation facilities, and long-term acute care hospitals.
This matters because post-hospital recovery care can be one of the most stressful parts of a senior’s healthcare journey.
A person may leave the hospital expecting rehab, therapy, or skilled nursing support. But if a Medicare Advantage plan requires prior authorization, the plan may need to approve that care before it is covered.
The concern raised by lawmakers is whether some insurers are using algorithms, software, or artificial intelligence in ways that may affect care decisions.
For seniors, this does not mean every Medicare Advantage plan is bad. It does mean beneficiaries should understand how their plan handles prior authorization, appeals, rehab coverage, and post-hospital care.
What Medicare beneficiaries should review
Before choosing or keeping a Medicare Advantage plan, ask:
- Does the plan require prior authorization for skilled nursing or rehab?
- What happens after a hospital stay?
- Are preferred rehab facilities in network?
- How does the plan handle appeals?
- Are doctors, hospitals, and specialists still in network?
- Has the plan changed its rules for 2027?
You can learn more about Medicare Advantage plan structure on our Medicare Advantage page.
Tuesday: Medicare Advantage May Be Stabilizing, But Reviews Still Matter
Another major update came from the Medicare Advantage market.
UnitedHealth Group reported second-quarter 2026 results and raised its full-year outlook. Public filings also showed that UnitedHealthcare Medicare & Retirement revenue was $42.4 billion in the second quarter of 2026, compared with $42.6 billion in the second quarter of 2025, while seniors served through Medicare Advantage had declined since year-end 2025.
In plain English, the Medicare Advantage market is still adjusting, but some of the extreme uncertainty from earlier carrier pullbacks may be calming.
That does not mean beneficiaries should ignore their Annual Notice of Change.
A plan can remain in the county and still change important details, such as:
- Doctor networks
- Hospital access
- Prescription drug tiers
- Prior authorization rules
- Dental, vision, or hearing benefits
- Copays
- Maximum out-of-pocket limits
- Pharmacy contracts
For Medicare beneficiaries, “market stabilization” does not automatically mean “your plan stayed the same.”
It means the insurance companies may be adjusting their business model. Your personal review still matters.
You can read more about when plan changes may matter on our Change Medicare Plans After Open Enrollment guide.
Wednesday: Remote Patient Monitoring Gets More Attention
Remote patient monitoring is another Medicare issue worth watching.
Remote patient monitoring can include connected health tools such as blood pressure cuffs, weight scales, pulse oximeters, or other devices that send health information to a medical team.
For seniors with chronic conditions, these tools can be helpful. They may help doctors monitor blood pressure, heart failure, diabetes, weight changes, and other health concerns from home.
But federal oversight agencies have also raised concerns about improper billing and fraud in remote patient monitoring.
The HHS Office of Inspector General has warned that Medicare payments for remote patient monitoring have grown and that monitoring billing can help safeguard Medicare from fraud, waste, and abuse.
CMS also issued the Calendar Year 2027 Medicare Physician Fee Schedule proposed rule in July 2026, which includes proposed policy changes for Medicare physician payments and Part B services. Remote monitoring remains an area to watch as CMS and oversight agencies continue reviewing how these services are billed and delivered.
What seniors should watch for
If you use a remote monitoring device, ask:
- Who is actually monitoring the readings?
- Is your doctor’s office involved?
- Are you being billed for the service?
- Do you know what device you received?
- Are readings being reviewed regularly?
- Do you understand when the office will contact you?
Remote monitoring can be valuable, but seniors should be cautious about any device or service they did not request or do not understand.
Thursday: GLP-1 Bridge Prior Authorization Details Matter
The Medicare GLP-1 Bridge Program has created a lot of excitement because eligible beneficiaries may access certain GLP-1 medications for weight loss at a $50 monthly cost.
But prior authorization matters.
CMS says eligible beneficiaries must meet clinical criteria. For example, CMS’s Part D plan guidance says a beneficiary may qualify if they are at least 18 and had a BMI of 35 or higher at the time GLP-1 therapy began. CMS also lists a pathway for BMI of 30 or higher with certain diagnoses, such as heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease stage 3a or above.
That means documentation matters.
A doctor or healthcare provider may need to submit information showing the person meets the program criteria.
For seniors, the practical lesson is this:
Do not assume that a lower price at the pharmacy means every future refill will be simple. Make sure your provider understands the Medicare GLP-1 Bridge criteria and has the medical documentation needed to support the request.
What to ask your doctor
If you are trying to use the Medicare GLP-1 Bridge, ask your provider:
- Do I meet the Medicare GLP-1 Bridge criteria?
- What BMI or diagnosis documentation is needed?
- Is prior authorization required?
- Which medication is being prescribed?
- Is this medication covered through the Bridge or through my regular Part D plan?
- What happens if my medication changes?
- How will refills be handled?
You can also review our Medicare Part D Prescription page for broader drug plan information.
Friday: CMS Confirms Medicare GLP-1 Bridge Runs Through December 31, 2027
The biggest prescription drug update this week was CMS confirming that the Medicare GLP-1 Bridge will run through December 31, 2027.
CMS describes the Medicare GLP-1 Bridge as a short-term demonstration that provides eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1, 2026 and December 31, 2027.
CMS also states that the Bridge will allow the agency to collect additional data on GLP-1 utilization ahead of potential implementation of the BALANCE Model in Part D.
This is important because many beneficiaries may have expected GLP-1 access to quickly become part of standard Part D coverage. For now, the Bridge Program remains the key Medicare pathway for certain weight-loss GLP-1 access for eligible beneficiaries.
The budgeting issue beneficiaries should understand
The $50 monthly GLP-1 Bridge price may help eligible beneficiaries plan more clearly.
But beneficiaries should still ask how the Bridge interacts with their regular Part D plan costs, deductible, formulary, and out-of-pocket tracking.
When a medication is handled through a special program, it may not work the same way as a normal formulary drug inside a standard Part D plan.
Before assuming how it affects your yearly drug spending, call your plan, pharmacy, or Medicare advisor and ask directly.
What This Week Means for Medicare Beneficiaries
This week’s Medicare news points to one major theme:
Coverage details matter more than headlines.
A headline may say GLP-1 drugs are available for $50.
But the real questions are:
- Do you qualify?
- Does your provider have the right documentation?
- Is prior authorization required?
- Is the medication handled through the Bridge or your regular Part D plan?
- Will it count toward your normal Part D costs?
A headline may say Medicare Advantage is stabilizing.
But your personal questions are:
- Are your doctors still in network?
- Are your prescriptions still covered?
- Did your plan change copays?
- Did prior authorization rules change?
- Is your preferred hospital still included?
A headline may say remote monitoring helps seniors stay healthier at home.
But you still need to know:
- Who is monitoring your device?
- Is it medically necessary?
- Are you being billed?
- Did you agree to the service?
Medicare Review Checklist After This Week’s News
Before the next Medicare enrollment period, review:
- Your prescription list
- Your Part D formulary
- Your pharmacy network
- Your Medicare Advantage provider network
- Prior authorization requirements
- Rehab and skilled nursing coverage
- GLP-1 Bridge eligibility, if relevant
- Remote monitoring bills or devices
- Your Annual Notice of Change
- Your total expected yearly costs
For extra drug cost help, visit our Medicare Extra Help page.
For help with Medicare Savings Programs, visit our Medicare Savings Program page.
Official Medicare and Healthcare Sources
For additional information, review these official and reputable sources:
- CMS Medicare GLP-1 Bridge
- CMS Information for Part D Plans
- CMS Information for Providers
- Medicare.gov Weight Loss Drug Coverage
- CMS 2027 Physician Fee Schedule Proposed Rule
- HHS OIG Remote Patient Monitoring Oversight
- Senate Inquiry on Medicare Advantage Prior Authorization
Local Medicare Help
Medicare changes can feel overwhelming, especially when drug coverage, prior authorization, doctor networks, and new CMS programs are all changing at the same time.
If you want help reviewing how these updates may affect your Medicare coverage, call Medicare Plan Assistance at (561) 808-9410.
Our goal is to help you understand your Medicare options, save time, avoid confusion, and review your coverage before costly surprises happen.
Frequently Asked Questions
What was the biggest Medicare news this week?
One of the biggest updates was CMS confirming that the Medicare GLP-1 Bridge Program runs through December 31, 2027 for eligible Medicare Part D beneficiaries.
Does Medicare cover GLP-1 drugs for weight loss?
Medicare may cover certain GLP-1 drugs through the temporary Medicare GLP-1 Bridge Program if the beneficiary has Medicare Part D coverage and meets eligibility criteria.
How much do GLP-1 drugs cost through the Medicare GLP-1 Bridge?
CMS says eligible beneficiaries may access certain covered GLP-1 medications through the Bridge for $50 per month.
Do GLP-1 Bridge drugs automatically count like normal Part D drugs?
Beneficiaries should not assume that. Because the Bridge is a special CMS demonstration, beneficiaries should ask their plan or pharmacy how costs are processed and whether they count toward normal Part D cost-sharing totals.
What is prior authorization in Medicare Advantage?
Prior authorization means the plan may need to approve certain services before it agrees to cover them. This can apply to services such as rehab, skilled nursing care, imaging, procedures, and other medical services depending on the plan.
Why are lawmakers looking at Medicare Advantage prior authorization?
Senators have requested records from major Medicare Advantage insurers related to prior authorization practices, post-acute care denials, and the use of algorithms, software, or AI in coverage decisions.
What is remote patient monitoring?
Remote patient monitoring uses connected devices, such as blood pressure cuffs or weight scales, to send health data to a provider or care team.
Should I review my Medicare plan after this news?
Yes. Medicare beneficiaries should review doctors, prescriptions, prior authorization rules, drug costs, pharmacy networks, and plan changes before choosing or keeping coverage.
Final Word
This week’s Medicare news shows why beneficiaries should not rely only on headlines.
The Medicare GLP-1 Bridge may help eligible people access certain weight-loss medications. Medicare Advantage plans may be stabilizing financially, but prior authorization remains under scrutiny. Remote monitoring can be useful, but billing and oversight concerns remain important.
The best step is to review your coverage before you need it.
Call Medicare Plan Assistance at (561) 808-9410 for local Medicare help.